Whether you choose to use AOD 9604 or another fat loss tool, remember that consistency, proper diet, and exercise are key factors in achieving long-term success
[5] [6] Early-phase clinical trials including a Phase 2 trial published in the New England Journal of Medicine (2023) have reported significant reductions in body weight and improvements in metabolic markers, though this evidence remains preliminary and is not sufficient to establish a clinical dosing or reconstitution standard
not intended for clinical or household applications
AOD 9604 Comparison: Related Research Compounds The table below compares AOD 9604 with two growth hormonereleasing hormone analogues, CJC-1295 and tesamorelin
Importantly, AOD-9604 does not appear to bind to the growth hormone receptor itself in cell-binding studies
All of these situations require a solvent that carries zero microbial load and acts as a preventative against microbial growth